BioMarin Pharmaceutical Inc

Founded in 1997 BioMarin has developed and commercialized four products in this time. With over 700 employees and a head office in California, clinical research is conducted on an international scale with the main area of focus being rare ‘orphan’ genetic diseases.

The strategy is to provide rapid access to treatment for patients with serious unmet medical needs, optimizing powerful biology with demonstrated potential and development clarity, accelerating approval process, strategic pipeline development